New Bird Flu Map Reveals Virus's Invisible Highways Across America

MEMPHIS, TN – April 15, 2026 – An international team of scientists has unveiled the first comprehensive map charting the continental spread of a dominant avian influenza strain through North America, providing a critical breakthrough in understanding how the virus travels and the ongoing threat it poses to both animal and human health. The groundbreaking study, led by researchers at St. Jude Children's Research Hospital and published today in Nature Medicine, explains the source of severe human infections in 2024 and offers a mix of reassurance and stark warning for public health officials.

The research meticulously tracks a novel H5N1 strain, dubbed D1.1, which rapidly established dominance in wild bird populations. By connecting disparate regional data points into a single, cohesive picture, the map visualizes the virus's journey along ancient migratory flyways, effectively revealing the invisible highways it uses to traverse the continent.

Charting the Viral Highways

The story of the D1.1 strain began in late 2024, when the St. Jude group first detected the novel virus. It quickly became clear this was not just another variant. Alarming reports emerged from multiple surveillance sites indicating D1.1 was outcompeting other strains. This prompted a massive collaborative effort, uniting institutions across the United States and Canada to pool their findings.

By sequencing and analyzing samples from wild birds across the continent, researchers traced the strain's origins to Alaska and British Columbia. From there, the map shows a clear and predictable progression as the virus moved south and east, carried by waterfowl like ducks and geese along well-established migratory pathways. This effort transformed fragmented observations into a powerful narrative of viral expansion.

"Combining information collected from multiple partners, we've documented the entire continental spread of a newly dominant strain of highly pathogenic avian influenza virus through wild bird populations," said corresponding author Richard Webby, PhD, of the St. Jude Department of Host-Microbe Interactions. "We've shown the value of connecting what are usually regional findings into a single comprehensive map to understand the strain's spread."

Solving the Puzzle of Human Infections

This new continental perspective provided the missing piece to a disturbing puzzle from 2024: a series of severe human avian flu infections. While the U.S. saw a total of 70 confirmed human H5N1 cases that year—most linked to exposure to infected dairy cows or poultry—a handful of severe cases had appeared geographically scattered, making their source unclear. The D1.1 map provided the direct link.

Every one of these severe cases was caused by the D1.1 strain. When overlaid with the new map, the locations of human infections no longer seemed random. Instead, they directly correlated with areas where D1.1 had recently become the dominant strain in the local wild bird population.

"We could connect all the severe cases with the wild bird map," explained co-first author Walter Harrington, PhD, also of St. Jude. "We had reason to suspect wild birds played a role, but the extent of spread in wild bird populations wasn't clear. Without that context, the human infections appeared geographically scattered; with it, the strain's emergence correlated with where we saw it becoming the dominant strain in wild birds."

A Double-Edged Sword: Low Risk, High Stakes

While the map confirms birds as the likely source of human infections, the study also delivered some cautiously optimistic news regarding pandemic potential. Genetic analysis of the D1.1 virus revealed that it has not yet acquired the key mutations known to facilitate efficient human-to-human transmission. For now, the CDC's assessment of the risk to the general public remains low.

"Fortunately, we saw that these viruses remained mostly avian, with none of the major mutations known to enable efficient human infections," said co-first author Lisa Kercher, PhD, from St. Jude. This finding is crucial, as the greatest fear with any zoonotic virus is its adaptation for easy spread between people.

However, the assessment is not entirely reassuring. Dr. Kercher noted the virus did possess a mutation conferring resistance to a common antiviral drug. On the other hand, tests against existing candidate vaccines for humans were promising. "When we tested existing candidate vaccines, they showed significant cross-reactivity, suggesting they will likely be effective to help control the virus," she added. This suggests that current stockpiles could provide a vital line of defense if needed.

Despite the low population-level risk, the severity of the disease in the few individuals who do get infected is a potent reminder of the virus's danger. Experts stress that influenza viruses evolve rapidly, and the situation could change. The widespread presence of H5N1 in birds, and more recently in mammals like dairy cattle, provides the virus with countless opportunities to mutate.

An Unprecedented Ecological Toll

The D1.1 strain is a chapter in a much larger crisis. The broader H5N1 clade 2.3.4.4b, which entered North America in 2021, has caused what the press release termed "havoc" in wild birds and the poultry industry. The scale of the devastation is staggering. Since January 2022, H5N1 has been detected in over 9,200 wild birds and has led to the loss of over 136 million commercial and backyard birds in the United States alone.

The economic fallout has been immense, with losses from a prior year's outbreak estimated between $2.5 and $3 billion, stemming from depopulation, disposal, and trade restrictions. The virus has also demonstrated an alarming ability to adapt, making a shocking jump to dairy cows in March 2024 and subsequently spreading to herds across multiple states, adding another dimension to the outbreak.

Ecologically, the virus has been catastrophic, causing mass die-offs in wild bird populations and spilling over into at least 48 different mammal species. The relentless spread underscores the urgency of surveillance efforts like the one pioneered by St. Jude and its partners.

This new map serves as more than just a historical record; it is a blueprint for the future of disease surveillance. By understanding how these viruses move through wildlife, public health officials can better anticipate where threats might emerge next.

"We were lucky enough to join groups from Canada and throughout the U.S. to understand this virus," Webby concluded. "That lets us put human cases in the context of the strain's greater spread and gives us a model to continue to monitor and assess the threat of these highly pathogenic influenza viruses in the future."